An international study presented in London found that halving patient out-of-pocket costs for fertility treatment was associated with a 2.67x increase in births achieved via assisted reproductive technology (ART). The article frames the result as strong evidence that reducing direct patient costs can materially improve ART utilization and outcomes.
An international study presented in London found that halving patient out-of-pocket costs for fertility treatment was associated with a 2.67x increase in births achieved via assisted reproductive technology (ART). The article frames the result as strong evidence that reducing direct patient costs can materially improve ART utilization and outcomes.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request DemoOverall Sentiment
mildly positive
Sentiment Score
0.15